A Randomised Controlled Trial Of NMDA Antagonist, Memantine, For The Treatment Of Borderline Personality Disorder
Funder
National Health and Medical Research Council
Funding Amount
$993,067.00
Summary
Borderline Personality Disorder (BPD) affects 5.9% of Australians and is a poorly understood mental illness with no clear medication treatment. The key symptoms of BPD all stem from impaired cognitive processes. Our early data shows improvement of symptoms with memantine - a cognitive enhancing drug used in Alzheimer’s disease.We plan to conduct a clinical trial; giving either 20mg memantine or placebo to 150 people with BPD across 2 Victorian sites.
What's In A Conversation? Discourse Correlates Of Concepts In The Conversational Model Of Psychotherapy
Funder
National Health and Medical Research Council
Funding Amount
$240,952.00
Summary
How and why does therapeutic talk assist people with mental health disorders to change and restore their sense of self? How do psychiatrists read the potential for such change in the discourse of their patients? This collaborative project, between psychiatry and linguistics, investigates the role of language in providing both strategies for change and evidence of change in the Conversational Model of psychotherapy. The project will examine the linguistic patterns that occur in the forms of talk ....How and why does therapeutic talk assist people with mental health disorders to change and restore their sense of self? How do psychiatrists read the potential for such change in the discourse of their patients? This collaborative project, between psychiatry and linguistics, investigates the role of language in providing both strategies for change and evidence of change in the Conversational Model of psychotherapy. The project will examine the linguistic patterns that occur in the forms of talk used by therapists employing the Conversational Model of Psychotherapy, in order to produce a better understanding of certain mental illnesses, and how they can be treated. Specifically, it will: 1. describe, linguistically, four key discourse categories of the Conversational Model that are taken as indicators of progress in patients with Borderline Personality Disorder 2. explain the therapeutic work of such discourse - what is it about these particular language resources that facilitates the observed changes in patients' discourse and mind? 3. assess the stability of key discourse categories of the Conversational Model, and test the ability of a linguistic profile to reliably distinguish between key therapeutic categories as used by different clinicians. The positive effects of Conversational Therapy on incidence of self harm, violence, hospital stays, drug use and self-reported symptoms in this group have been well documented and are especially impressive given that many of the patients in these studies had been turned away from other forms of treatment as unresponsive. By understanding better how this therapy works in a patient group that is typically resistant to treatment but responsive to this particular treatment, we hope to improve health outcomes for people diagnosed with Borderline Personality Disorder. In the longer term we expect this research to help improve techniques for enhancing the mental health of Australians more generally.Read moreRead less
Selective Serotonin Re-uptake Inhibitors (SSRIs) And Osteoporosis: Mechanisms And Clinical Consequences
Funder
National Health and Medical Research Council
Funding Amount
$422,964.00
Summary
Selective serotonin re-uptake inhibitors (SSRIs) are commonly used to treat depression. Serotonin is not unique to the brain but is also used by other cells in the body, including bone cells. In this project the influence of SSRIs on human osteoclast and osteoblast formation and function will be investigated in a laboratory. Additionally, the impact of SSRI use on bone loss and fracture risk in a community sample of women and men will be investigated. These studies will determine if exposure to ....Selective serotonin re-uptake inhibitors (SSRIs) are commonly used to treat depression. Serotonin is not unique to the brain but is also used by other cells in the body, including bone cells. In this project the influence of SSRIs on human osteoclast and osteoblast formation and function will be investigated in a laboratory. Additionally, the impact of SSRI use on bone loss and fracture risk in a community sample of women and men will be investigated. These studies will determine if exposure to SSRIs adversely impact bone health.Read moreRead less
The Prevention, Early Detection, & Effective Management Of Neurocognitive Disorders In The Elderly
Funder
National Health and Medical Research Council
Funding Amount
$4,929,014.00
Summary
The unprecedented greying of the world population is posing a major challenge to health care in meeting the needs of older individuals with cognitive disorders such as Alzheimer�s disease. At the same time, drugs are being developed to prevent these disorders, or to treat them effectively. Our proposal is a comprehensive attempt at dealing with the neuropsychiatric aspects of these neurocognitive disorders. Our group is endeavouring to better define the early stages of these disorders, and study ....The unprecedented greying of the world population is posing a major challenge to health care in meeting the needs of older individuals with cognitive disorders such as Alzheimer�s disease. At the same time, drugs are being developed to prevent these disorders, or to treat them effectively. Our proposal is a comprehensive attempt at dealing with the neuropsychiatric aspects of these neurocognitive disorders. Our group is endeavouring to better define the early stages of these disorders, and studying methods of detecting them at an early stage, using the latest neuropsychological and neuroimaging techniques. We wish to investigate new drugs for the prevention of dementia. Much of dementia is not treated early because of lack of training of primary care physicians in identifying dementia, and we are developing methods to deal with this problem. We are also examining the role of cognitive disorders in accidents and suicides in the elderly, and the development of depression. We are determining the role of psychiatric disorders in the care of these patients, and the methods of alleviating the burden of disease. We expect that this research will make a major impact on health policy for these disorders in Australia. We also hope to make our Program the premier centre for training in geriatric neuropsychiatry.Read moreRead less
Psychiatric Disorders, Psychotropic Agents And Bone Health: From Benchtop To Bedside.
Funder
National Health and Medical Research Council
Funding Amount
$447,744.00
Summary
Just under half of all people with a psychiatric disorder have a chronic physical illness. One common and neglected comorbidity is osteoporosis. Dr Williams has brought together a multi-disciplinary team of researchers and clinicians that are gathering laboratory through to clinical evidence regarding the interplay between psychiatric disorders, the medication used to treat these disorders and bone health with the aim of informing clinical practice and guiding clinical choice.
Inflammatory Cytokines As Risk Factors For The Development Of Both Depression And Osteoporosis In Men
Funder
National Health and Medical Research Council
Funding Amount
$381,091.00
Summary
Both depression and osteoporosis impose a substantial public health burden on society and there is now research to suggest that these conditions are related. This study will examine a potential common mechanism, systemic inflammation, which may underlie both diseases. It will focus on markers of systemic inflammation, examine their association to both depression and bone fragility and determine what role they play in explaining the relationship between the disorders.
It is widely accepted that just under half of all people with bipolar disorder have a chronic physical illness. The one neglected comorbidity is osteoporosis. In this project, the association between bipolar disorder and bone fragility will be examined. Additionally, a potential common mechanism, systemic inflammation, which may underlie both diseases, will be investigated as a potential mediator of the relationship.